News

Title published

Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018

The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

21-Aug-2014

Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020

Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

19-Aug-2014

Asia-Pacific, Led by China, Drive the Global Methanol Industry

China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

19-Aug-2014

Diagnostic X-ray Imaging Market worth $4.0 billion by 2020

GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

10-Jul-2014

Graft-Versus-Host Disease Market Forecast to 2023

Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

10-Jul-2014

Chronic Lymphocytic Leukemia (CLL) Treatment Market worth $3.3 billion by 2018

New Entrants to Boost Chronic Lymphocytic Leukemia Treatment Market Value to $3.3 Billion by 2018, says GlobalData. The introduction of several new drugs will accelerate growth in the Chronic Lymphocytic Leukemia (CLL) treatment market, from $1.4 billion in 2013 to …

10-Jul-2014

Global Biosimilars Market to Grow at a CAGR of 8.3%, to reach $262 billion by 2019

Lucrative Biosimilars Space to Erode Biologics Market from 2019, says GlobalData The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking …

10-Jul-2014

Saudi Pharmaceutical Market worth $5.9 billion by 2020

A high burden of chronic diseases, improving regulatory guidelines and the launch of new products will provide the necessary impetus for the growth of the pharmaceutical market in Saudi Arabia The Saudi pharmaceutical market is one of the largest markets …

10-Jul-2014

Mexico Pharmaceutical Market worth $22.5 billion by 2020

The healthcare market of Mexico has significant potential for growth. The increasing elderly population, prevalence of non-communicable diseases, improvements in regulatory guidelines, government support for the healthcare sector, and the North American Free Trade Agreement, which assures its members protection …

10-Jul-2014

The Global naval vessels and surface combatants market is set to see a CAGR of over 2% by 2024

Strategic Defense Intelligence’s The Global Naval Vessels and Surface Combatants Market 2014-2024 analyzes the Global naval vessels and surface combatants market size and drivers, including detailed analysis of the Global naval vessels and surface combatants industry over the next ten …

24-Jun-2014